• FDA Approves Odactra for House Dust Mite Allergies americanpharmaceuticalreview
    March 03, 2017
    The U.S. Food and Drug Administration has approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conj
  • FDA approves Odactra for house dust mite allergies worldpharmanews
    March 02, 2017
    The U.S. Food and Drug Administration today approved Odactra the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis).
PharmaSources Customer Service